Skip to content
Trial Eligibility
Menu

Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation

NCT07501078

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Ulcerative colitis (UC) is a disease that causes long-term inflammation in the digestive tract, and many people with this condition require surgery to remove the colon and create a new J-pouch for stool. Some patients develop a problem called pouchitis, where this pouch becomes inflamed. Current treatments are limited, and there are no known ways to prevent pouchitis from starting. This study is being done to find out if a natural mineral supplement called Aquamin® can help reduce inflammation and protect the gut lining in people with a J-pouch, and may reduce the risk of pouchitis.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Ulcerative Colitis
  • Ileal Pouch

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 to 80 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Muhammad N Aslam, MD
Last updated on ClinicalTrials.gov
October 2, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Michigan · 1

  • University of Michigan · Ann Arbor, MI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.